Galena Biopharma Fights the Negative Attention

Investment Opinion

Share Tweet

Galena Biopharma Fights the Negative Attention

Wondering what your next move should be in the market? can help lead the way. For free access to our complete stock reports, take a few minutes to register with us by clicking this link:

Galena Biopharma, Inc. (NASDAQ: GALE) – For an in-depth report on Galena Biopharma, Inc. follow:

Shares of Galena Biopharma closed down 14.35% this past Friday with 40.8 million shares traded. The stock was one of the biggest decliners on the NASDAQ. The company issued a letter to its shareholders in response to recent media attention stemming from a negative article by Galena felt it necessary, as a service to shareholders, to publicly respond to the discussions and set the record straight.

Worlds Inc. (OTCBB: WDDD) – For an in-depth report on Worlds Inc. follow:

Shares of WDDD closed up 11.76% this past Friday and was one of the biggest gainers in the OTCBB market. The stock traded roughly 580,000 shares without any news released by the company to explain the gains. The company announced last month that it had received its 9th patent from the U.S. Patent & Trademark Office (USPTO): no. 8,640,028 titled "System and Method for Enabling Users to Interact in a Virtual Space." The patent relates to computer architecture for three-dimensional graphical multi-user interactive virtual world systems also known as Massive Multiplayer Online Role Playing Games (MMORPG).

CafePress Inc. (NASDAQ: PRSS) – For an in-depth report on CafePress Inc. follow:

CafePress Inc. closed down 20.78% this past Friday with about 900,000 shares traded. The stock was one of the biggest droppers in the NASDAQ. The company reported financial results for the three months and full year ended December 31, 2013. “Sales of CafePress’ customized e-commerce offerings in the fourth quarter resulted in 2013 revenue growth of 13% over 2012,” said CEO Bob Marino. “Net revenues totaled $90.5 million, compared to $87.2 million in the fourth quarter of 2012.

Ellie Mae, Inc. (NYSE: ELLI) – For an in-depth report on Ellie Mae, Inc. follow:

Shares of Ellie Mae, Inc. closed up 17.87% last Friday with a little over 3 million shares traded. The stock was one of the biggest gainers in the NYSE. The big gain came after the company turned in solid fourth-quarter results and full-year guidance. Quarterly revenue came in at $30.4 million, which translated to adjusted net income of $5.3 million, or $0.18 per diluted share. Analysts, on average, were expecting earnings of $0.18 per share on sales of $29.84 million.


Disclosure: is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please read our report and visit our website, for complete risks and disclosures.